159 related articles for article (PubMed ID: 8887460)
1. Refinement and verification of the physiologically based dosimetry description for acrylonitrile in rats.
Kedderis GL; Teo SK; Batra R; Held SD; Gargas ML
Toxicol Appl Pharmacol; 1996 Oct; 140(2):422-35. PubMed ID: 8887460
[TBL] [Abstract][Full Text] [Related]
2. A physiologically based dosimetry description of acrylonitrile and cyanoethylene oxide in the rat.
Gargas ML; Andersen ME; Teo SK; Batra R; Fennell TR; Kedderis GL
Toxicol Appl Pharmacol; 1995 Oct; 134(2):185-94. PubMed ID: 7570594
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based pharmacokinetic model parameter estimation and sensitivity and variability analyses for acrylonitrile disposition in humans.
Sweeney LM; Gargas ML; Strother DE; Kedderis GL
Toxicol Sci; 2003 Jan; 71(1):27-40. PubMed ID: 12520073
[TBL] [Abstract][Full Text] [Related]
4. Conjugation of acrylonitrile and 2-cyanoethylene oxide with hepatic glutathione.
Kedderis GL; Batra R; Turner MJ
Toxicol Appl Pharmacol; 1995 Nov; 135(1):9-17. PubMed ID: 7482544
[TBL] [Abstract][Full Text] [Related]
5. Determination of tissue partition coefficients for volatile tissue-reactive chemicals: acrylonitrile and its metabolite 2-cyanoethylene oxide.
Teo SK; Kedderis GL; Gargas ML
Toxicol Appl Pharmacol; 1994 Sep; 128(1):92-6. PubMed ID: 8079360
[TBL] [Abstract][Full Text] [Related]
6. Rodent tissue distribution of 2-cyanoethylene oxide, the epoxide metabolite of acrylonitrile.
Kedderis GL; Batra R; Held SD; Loos MA; Teo SK
Toxicol Lett; 1993 Jul; 69(1):25-30. PubMed ID: 8356564
[TBL] [Abstract][Full Text] [Related]
7. Species comparison of acrylonitrile epoxidation by microsomes from mice, rats and humans: relationship to epoxide concentrations in mouse and rat blood.
Roberts AE; Kedderis GL; Turner MJ; Rickert DE; Swenberg JA
Carcinogenesis; 1991 Mar; 12(3):401-4. PubMed ID: 2009586
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent urinary excretion of acrylonitrile metabolites by rats and mice.
Kedderis GL; Sumner SC; Held SD; Batra R; Turner MJ; Roberts AE; Fennell TR
Toxicol Appl Pharmacol; 1993 Jun; 120(2):288-97. PubMed ID: 8511799
[TBL] [Abstract][Full Text] [Related]
9. Analysis of DNA Adducts and Mutagenic Potency and Specificity in Rats Exposed to Acrylonitrile.
Walker VE; Fennell TR; Walker DM; Bauer MJ; Upton PB; Douglas GR; Swenberg JA
Chem Res Toxicol; 2020 Jul; 33(7):1609-1622. PubMed ID: 32529823
[TBL] [Abstract][Full Text] [Related]
10. Epoxidation of acrylonitrile by rat and human cytochromes P450.
Kedderis GL; Batra R; Koop DR
Chem Res Toxicol; 1993; 6(6):866-71. PubMed ID: 8117926
[TBL] [Abstract][Full Text] [Related]
11. Species differences in the hydrolysis of 2-cyanoethylene oxide, the epoxide metabolite of acrylonitrile.
Kedderis GL; Batra R
Carcinogenesis; 1993 Apr; 14(4):685-9. PubMed ID: 8472333
[TBL] [Abstract][Full Text] [Related]
12. Derivation of noncancer reference values for acrylonitrile.
Kirman CR; Sweeney LM; Gargas ML; Strother DE; Collins JJ; Deskin R
Risk Anal; 2008 Oct; 28(5):1375-94. PubMed ID: 18761732
[TBL] [Abstract][Full Text] [Related]
13. Induction of oxidative stress in rat brain by acrylonitrile (ACN).
Jiang J; Xu Y; Klaunig JE
Toxicol Sci; 1998 Dec; 46(2):333-41. PubMed ID: 10048137
[TBL] [Abstract][Full Text] [Related]
14. Effect of glutathione depletion on the uptake of acrylonitrile vapors and on its irreversible association with tissue macromolecules.
Pilon D; Roberts AE; Rickert DE
Toxicol Appl Pharmacol; 1988 Sep; 95(2):265-78. PubMed ID: 2458635
[TBL] [Abstract][Full Text] [Related]
15. Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.
Kirman CR; Gargas ML; Marsh GM; Strother DE; Klaunig JE; Collins JJ; Deskin R
Regul Toxicol Pharmacol; 2005 Oct; 43(1):85-103. PubMed ID: 16099568
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Biomarkers of DNA Damage and Mutagenicity in Mice Exposed to Acrylonitrile.
Walker VE; Walker DM; Ghanayem BI; Douglas GR
Chem Res Toxicol; 2020 Jul; 33(7):1623-1632. PubMed ID: 32529832
[TBL] [Abstract][Full Text] [Related]
17. Blood concentrations of acrylonitrile in humans after oral administration extrapolated from in vivo rat pharmacokinetics, in vitro human metabolism, and physiologically based pharmacokinetic modeling.
Takano R; Murayama N; Horiuchi K; Kitajima M; Kumamoto M; Shono F; Yamazaki H
Regul Toxicol Pharmacol; 2010 Nov; 58(2):252-8. PubMed ID: 20600458
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.
Fisher JW; Whittaker TA; Taylor DH; Clewell HJ; Andersen ME
Toxicol Appl Pharmacol; 1989 Jul; 99(3):395-414. PubMed ID: 2749729
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific genotoxic effects of acrylamide and acrylonitrile.
Butterworth BE; Eldridge SR; Sprankle CS; Working PK; Bentley KS; Hurtt ME
Environ Mol Mutagen; 1992; 20(3):148-55. PubMed ID: 1396605
[TBL] [Abstract][Full Text] [Related]
20. Formation of 8-oxodeoxyguanosine in brain DNA of rats exposed to acrylonitrile.
Whysner J; Steward RE; Chen D; Conaway CC; Verna LK; Richie JP; Ali N; Williams GM
Arch Toxicol; 1998 Jun; 72(7):429-38. PubMed ID: 9708882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
